List of Tables
TABLE 1. ANTIBODY DRUG CONJUGATE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY CD30 ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY CD30 ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY ERBB2 ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY ERBB2 ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY ADCETRIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY ADCETRIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY BLENREP, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY BLENREP, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY ENHERTU, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY ENHERTU, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY KADCYLA, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY KADCYLA, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY PADCEV, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY PADCEV, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TRODELVY, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TRODELVY, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY CLEAVABLE LINKER, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY CLEAVABLE LINKER, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY LINKERLESS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY LINKERLESS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY NON-CLEAVABLE LINKER, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY NON-CLEAVABLE LINKER, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY BLOOD CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY BLOOD CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY LYMPHOMA, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MULTIPLE MYELOMA, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MULTIPLE MYELOMA, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY UROTHELIAL CANCER & BLADDER CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY UROTHELIAL CANCER & BLADDER CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY SPECIALIZED CANCER CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY SPECIALIZED CANCER CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS ANTIBODY DRUG CONJUGATE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS ANTIBODY DRUG CONJUGATE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 81. BRAZIL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 82. BRAZIL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 87. BRAZIL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 88. BRAZIL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 89. CANADA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 90. CANADA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 91. CANADA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 92. CANADA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 93. CANADA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 94. CANADA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 95. CANADA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 96. CANADA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 97. CANADA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 98. CANADA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 99. MEXICO ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 100. MEXICO ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 101. MEXICO ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 102. MEXICO ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 103. MEXICO ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 104. MEXICO ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 105. MEXICO ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 106. MEXICO ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 107. MEXICO ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 108. MEXICO ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 109. UNITED STATES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 110. UNITED STATES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 111. UNITED STATES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 112. UNITED STATES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 113. UNITED STATES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 114. UNITED STATES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 115. UNITED STATES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 116. UNITED STATES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 117. UNITED STATES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 118. UNITED STATES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 119. UNITED STATES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 120. UNITED STATES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 122. ASIA-PACIFIC ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 124. ASIA-PACIFIC ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 126. ASIA-PACIFIC ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 128. ASIA-PACIFIC ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 130. ASIA-PACIFIC ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC ANTIBODY DRUG CONJUGATE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 132. ASIA-PACIFIC ANTIBODY DRUG CONJUGATE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 133. AUSTRALIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 134. AUSTRALIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 135. AUSTRALIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 136. AUSTRALIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 137. AUSTRALIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 138. AUSTRALIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 139. AUSTRALIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 140. AUSTRALIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 141. AUSTRALIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 142. AUSTRALIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 143. CHINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 144. CHINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 145. CHINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 146. CHINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 147. CHINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 148. CHINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 149. CHINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 150. CHINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 151. CHINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 152. CHINA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 153. INDIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 154. INDIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 155. INDIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 156. INDIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 157. INDIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 158. INDIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 159. INDIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 160. INDIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 161. INDIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 162. INDIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 163. INDONESIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 164. INDONESIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 165. INDONESIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 166. INDONESIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 167. INDONESIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 168. INDONESIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 169. INDONESIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 170. INDONESIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 171. INDONESIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 172. INDONESIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 173. JAPAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 174. JAPAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 175. JAPAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 176. JAPAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 177. JAPAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 178. JAPAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 179. JAPAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 180. JAPAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 181. JAPAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 182. JAPAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 183. MALAYSIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 184. MALAYSIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 185. MALAYSIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 186. MALAYSIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 187. MALAYSIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 188. MALAYSIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 189. MALAYSIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 190. MALAYSIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 191. MALAYSIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 192. MALAYSIA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 193. PHILIPPINES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 194. PHILIPPINES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 195. PHILIPPINES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 196. PHILIPPINES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 197. PHILIPPINES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 198. PHILIPPINES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 199. PHILIPPINES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 200. PHILIPPINES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 201. PHILIPPINES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 202. PHILIPPINES ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 203. SINGAPORE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 204. SINGAPORE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 205. SINGAPORE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 206. SINGAPORE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 207. SINGAPORE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 208. SINGAPORE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 209. SINGAPORE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 210. SINGAPORE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 211. SINGAPORE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 212. SINGAPORE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 213. SOUTH KOREA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 214. SOUTH KOREA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 215. SOUTH KOREA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 216. SOUTH KOREA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 217. SOUTH KOREA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 218. SOUTH KOREA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 219. SOUTH KOREA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 220. SOUTH KOREA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 221. SOUTH KOREA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 222. SOUTH KOREA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 223. TAIWAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 224. TAIWAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 225. TAIWAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 226. TAIWAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 227. TAIWAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 228. TAIWAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 229. TAIWAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 230. TAIWAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 231. TAIWAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 232. TAIWAN ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 233. THAILAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 234. THAILAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 235. THAILAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 236. THAILAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 237. THAILAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 238. THAILAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 239. THAILAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 240. THAILAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 241. THAILAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 242. THAILAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 243. VIETNAM ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 244. VIETNAM ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 245. VIETNAM ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 246. VIETNAM ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 247. VIETNAM ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 248. VIETNAM ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 249. VIETNAM ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 250. VIETNAM ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 251. VIETNAM ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 252. VIETNAM ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA ANTIBODY DRUG CONJUGATE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 265. DENMARK ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 266. DENMARK ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 267. DENMARK ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 268. DENMARK ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 269. DENMARK ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 270. DENMARK ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 271. DENMARK ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 272. DENMARK ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 273. DENMARK ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 274. DENMARK ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 275. EGYPT ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 276. EGYPT ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 277. EGYPT ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 278. EGYPT ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 279. EGYPT ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 280. EGYPT ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 281. EGYPT ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 282. EGYPT ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 283. EGYPT ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 284. EGYPT ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 285. FINLAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 286. FINLAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 287. FINLAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 288. FINLAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 289. FINLAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 290. FINLAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 291. FINLAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 292. FINLAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 293. FINLAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 294. FINLAND ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 295. FRANCE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 296. FRANCE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 297. FRANCE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 298. FRANCE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 299. FRANCE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 300. FRANCE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 301. FRANCE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 302. FRANCE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 303. FRANCE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 304. FRANCE ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 305. GERMANY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 306. GERMANY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 307. GERMANY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 308. GERMANY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 309. GERMANY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 310. GERMANY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 311. GERMANY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 312. GERMANY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 313. GERMANY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 314. GERMANY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 315. ISRAEL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 316. ISRAEL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 317. ISRAEL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 318. ISRAEL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 319. ISRAEL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 320. ISRAEL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 321. ISRAEL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 322. ISRAEL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 323. ISRAEL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 324. ISRAEL ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 325. ITALY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 326. ITALY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2024-2030 (USD MILLION)
TABLE 327. ITALY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 328. ITALY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 329. ITALY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 330. ITALY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 331. ITALY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 332. ITALY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 333. ITALY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 334. ITALY ANTIBODY DRUG CONJUGATE MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 335. NETHERLANDS ANTIBODY DRUG CONJUGATE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2023 (USD MILLION)
TABLE 336. NETHERLANDS ANTIBODY DRUG